Document is current
Any future updates will be listed below
-
Authors
van Rijthoven, Mart https://orcid.org/0000-0003-3758-4348
Obahor, Simon https://orcid.org/0000-0001-9144-6435
Pagliarulo, Fabio
van den Broek, Maries https://orcid.org/0000-0002-9489-3692
Schraml, Peter
Moch, Holger https://orcid.org/0000-0002-7986-2839
van der Laak, Jeroen https://orcid.org/0000-0001-7982-0754
Ciompi, Francesco
Silina, Karina https://orcid.org/0000-0003-3947-2710
- License Information
-
More Information
Article History
Received: 8 May 2023
Accepted: 30 November 2023
First Online: 5 January 2024
Competing interests
: J.v.d.L. was a member of the advisory boards of Philips, the Netherlands and ContextVision, Sweden, and received research funding from Philips, the Netherlands, ContextVision, Sweden, and Sectra, Sweden in the last 5 years. He is chief scientific officer (CSO) and shareholder of Aiosyn BV, the Netherlands. F.C. was Chair of the Scientific and Medical Advisory Board of TRIBVN Healthcare, France, and received advisory board fees from TRIBVN Healthcare, France in the last 5 years. He is shareholder of Aiosyn BV, the Netherlands. F.C. is an Editorial Board Member for Communications Medicine, but was not involved in the editorial review or peer review, nor in the decision to publish this article. All other authors declare no competing interests.
